{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:37:08Z","timestamp":1767983828969,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.coi.2009.07.010","type":"journal-article","created":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T04:36:27Z","timestamp":1250138187000},"page":"569-572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Management of the highly sensitized patient"],"prefix":"10.1016","volume":"21","author":[{"given":"Frans HJ","family":"Claas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilias IN","family":"Doxiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2009.07.010_bib1","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1600-6135.2003.00273.x","article-title":"Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk","volume":"3","author":"Gebel","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2009.07.010_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Eng J Med"},{"key":"10.1016\/j.coi.2009.07.010_bib3","series-title":"Histocompatibility Testing","first-page":"451","article-title":"A proposal for international cooperation in organ transplantation; Eurotransplant","author":"Van Rood","year":"1967"},{"key":"10.1016\/j.coi.2009.07.010_bib4","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/00007890-199811150-00007","article-title":"The new Eurotransplant kidney allocation system: report one year after implementation","volume":"66","author":"De Meester","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.TP.0000129260.86766.67","article-title":"The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft survival","volume":"78","author":"Claas","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib6","first-page":"99","article-title":"The relevance of proficiency testing for Laboratories involved in cadaveric transplantation and its consequences for graft survival","author":"Doxiadis","year":"2000","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.coi.2009.07.010_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.coi.2005.07.010","article-title":"Extending options for highly sensitized patients to receive a suitable kidney graft","author":"Doxiadis","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2009.07.010_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.humimm.2005.01.007","article-title":"The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies","volume":"66","author":"Zoet","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.coi.2009.07.010_bib9_1","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u2018Natural\u2019 human leukocyte antigen antibodies found in nonalloimmunized healthy males","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.coi.2008.06.010","article-title":"Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation","volume":"20","author":"Duquesnoy","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2009.07.010_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.tb00379.x","article-title":"HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates","volume":"17","author":"Duquesnoy","year":"2004","journal-title":"Transplant Int"},{"key":"10.1016\/j.coi.2009.07.010_bib12","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2741\/2770","article-title":"The problem of transplanting the sensitized patients: whose problem is it?","volume":"13","author":"Jackson","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.coi.2009.07.010_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/TP.0b013e31817c90f5","article-title":"Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients","volume":"86","author":"Fuggle","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/IR:29:1-3:041","article-title":"Evolution of HLA antibody detection: technology emulating biology","volume":"29","author":"Bray","year":"2004","journal-title":"Immunol Res"},{"key":"10.1016\/j.coi.2009.07.010_bib15","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1097\/01.tp.0000246311.43634.0a","article-title":"Prediction of crossmatch outcome of highly sensitized patients by single and\/or multiple antigen bead luminex assay","volume":"82","author":"Vaidya","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.humimm.2008.06.013","article-title":"Detecting and monitoring human leukocyte antigen specific antibodies","volume":"69","author":"Zachary","year":"2008","journal-title":"Hum Immunol"},{"key":"10.1016\/j.coi.2009.07.010_bib17_1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/TP.0b013e31816b3ed1","article-title":"Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients","volume":"85","author":"Van den Berg-Loonen","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/TP.0b013e31816b1c37","article-title":"Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?","volume":"85","author":"Gupta","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MOT.0b013e3283028312","article-title":"Antibodies, isotypes and complement in allograft rejection","volume":"13","author":"B\u00f6hmig","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.coi.2009.07.010_bib20","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/j.1600-6143.2007.01944.x","article-title":"Renal transplantation in patients with pretransplant donor specific antibodies and negative flow cytometry crossmatches","volume":"7","author":"Patel","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2009.07.010_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1744-313X.2008.00800.x","article-title":"HLA antibody testing: a tool to facilitate not to prevent organ transplantation","volume":"35","author":"Claas","year":"2008","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.coi.2009.07.010_bib22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/TP.0b013e3181908f60","article-title":"Hurdles, barriers, and successes of a national living donor kidney exchange program","volume":"86","author":"De Klerk","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/TP.0b013e3181812f85","article-title":"Utilization and outcome of kidney paired donation in the United States","volume":"86","author":"Segev","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib24","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1097\/TP.0b013e3181909035","article-title":"The development of a successful multiregional kidney paired donation program","volume":"86","author":"Hanto","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib25","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1600-6143.2007.01935.x","article-title":"Expanding kidney paired donation through participation by compatible pairs","volume":"10","author":"Gentry","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.coi.2009.07.010_bib26_1","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.2741\/2932","article-title":"Strategies to expand the living donor pool for kidney transplantation","volume":"13","author":"De Klerk","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.coi.2009.07.010_bib27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted in cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib28","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower sensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.coi.2009.07.010_bib29_1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Eng J Med"},{"key":"10.1016\/j.coi.2009.07.010_bib30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/TP.0b013e3181856f98","article-title":"Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy","volume":"86","author":"Reinsmoen","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib31","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.transproceed.2008.07.046","article-title":"Rituximab in highly sensitized kidney transplant patients","volume":"40","author":"Munoz","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.coi.2009.07.010_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000170864","article-title":"Therapeutic strategies in management of the highly HLA-sensitized and ABO incompatible transplant recipients","volume":"162","author":"Jordan","year":"2009","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.coi.2009.07.010_bib33_1","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.coi.2009.07.010_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.transproceed.2008.10.073","article-title":"Proteasome inhibition reduces donor specific antibody levels","volume":"41","author":"Everly","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.coi.2009.07.010_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2009.04.019","article-title":"Monitoring and treating posttransplant human leukocyte antigen antibodies","author":"Everly","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.coi.2009.07.010_bib36","unstructured":"Claas FHJ, Rahmel A, Doxiadis IIN, Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program, Transplantation in press."}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791509001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791509001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:26:11Z","timestamp":1760603171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791509001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0952791509001435"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2009.07.010","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of the highly sensitized patient","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2009.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}